Actuate Therapeutics (ACTU) P/E (2024 - 2026)
Actuate Therapeutics (ACTU) P/E from Sep 30, 2024 to Jun 3, 2026. The TTM Actuate Therapeutics (ACTU) P/E is -1.90. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Actuate Therapeutics (ACTU)
| Year | P/E | Change |
|---|---|---|
| 2026 | -1.90 | -67.58% |
| 2025 | -5.87 | -53.11% |
| 2024 | -12.52 | N/A |
Comparison Actuate Therapeutics (ACTU) P/E with competitors
Actuate Therapeutics (ACTU) P/E is -1.90.